blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2277510

EP2277510 - Controlled release preparation [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.11.2019
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  23.11.2018
FormerGrant of patent is intended
Status updated on  15.07.2018
FormerExamination is in progress
Status updated on  21.02.2017
Most recent event   Tooltip09.07.2021Lapse of the patent in a contracting state
New state(s): HU		published on 11.08.2021  [2021/32]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
[2015/27]
Former [2011/04]For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku
Osaka 540-08645 / JP
Inventor(s)01 / Akiyama, Yohko
4-1-3-803, Takakaichominami
Omihachiman-shi
Shiga 523-0898 / JP
02 / Kurasawa, Takashi
Takeda Pharmaceutical Company Limited
17-58 Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka / JP
03 / Bando, Hiroto
Takeda Pharmaceutical Company Limited
17-58 Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka / JP
04 / Nagahara, Naoki
Takeda Pharmaceutical Company Limited
17-58 Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka / JP
 [2018/52]
Former [2011/10]01 / Akiyama, Yohko
4-1-3-803, Takakaichominami Omihachiman-shi
Shiga 523-0898 / JP
02 / Kurasawa, Takashi
Takeda Pharmaceutical Company Limited 17-58 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka / JP
03 / Bando, Hiroto
Takeda Pharmaceutical Company Limited 17-58 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka / JP
04 / Nagahara, Naoki
Takeda Pharmaceutical Company Limited 17-58 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka / JP
Former [2011/04]01 / Akiyama, Yohko
Takeda Pharmaceutical Company Limited 17-58 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka / JP
02 / Kurasawa, Takashi
Takeda Pharmaceutical Company Limited 17-58 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka / JP
03 / Bando, Hiroto
Takeda Pharmaceutical Company Limited 17-58 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka / JP
04 / Nagahara, Naoki
Takeda Pharmaceutical Company Limited 17-58 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka / JP
Representative(s)Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
[N/P]
Former [2018/52]Elkington & Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2014/30]Kingsbury, Oliver William, et al
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2011/04]Wright, Robert Gordon McRae
Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks
Kent TN13 1XR / GB
Application number, filing date10177692.015.10.2003
[2011/04]
Priority number, dateJP2002030187616.10.2002         Original published format: JP 2002301876
JP2003006633612.03.2003         Original published format: JP 2003066336
[2011/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2277510
Date:26.01.2011
Language:EN
[2011/04]
Type: A3 Search report 
No.:EP2277510
Date:01.02.2012
Language:EN
[2012/05]
Type: B1 Patent specification 
No.:EP2277510
Date:26.12.2018
Language:EN
[2018/52]
Search report(s)(Supplementary) European search report - dispatched on:EP04.01.2012
ClassificationIPC:A61K9/20, A61K9/28, A61K9/50, A61K31/4439
[2011/04]
CPC:
A61K9/2013 (EP,US); A61K9/20 (KR,NO); A61K9/5026 (US);
A61K31/4439 (EP,NO,US); A61K9/2022 (NO); A61K9/28 (NO);
A61K9/2833 (NO); A61K9/2846 (EP,US); A61K9/48 (KR);
A61K9/5042 (US); A61K9/5073 (EP,US); A61K9/5078 (EP,US);
A61P1/04 (EP); A61P35/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2018/52]
Former [2011/04]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL30.07.2012
LT30.07.2012
LV30.07.2012
MK30.07.2012
TitleGerman:Zusammensetzung mit verzögerter Freisetzung.[2011/04]
English:Controlled release preparation[2011/04]
French:Préparation à libération contrôlée.[2011/04]
Examination procedure30.07.2012Amendment by applicant (claims and/or description)
30.07.2012Examination requested  [2012/37]
17.10.2016Despatch of a communication from the examining division (Time limit: M06)
26.04.2017Reply to a communication from the examining division
16.07.2018Communication of intention to grant the patent
14.11.2018Fee for grant paid
14.11.2018Fee for publishing/printing paid
14.11.2018Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP03754116.6  / EP1553929
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030754116) is  10.04.2006
Opposition(s)27.09.2019No opposition filed within time limit [2019/49]
Fees paidRenewal fee
22.09.2010Renewal fee patent year 03
22.09.2010Renewal fee patent year 04
22.09.2010Renewal fee patent year 05
22.09.2010Renewal fee patent year 06
22.09.2010Renewal fee patent year 07
22.09.2010Renewal fee patent year 08
11.10.2011Renewal fee patent year 09
11.10.2012Renewal fee patent year 10
14.10.2013Renewal fee patent year 11
14.10.2014Renewal fee patent year 12
12.10.2015Renewal fee patent year 13
11.10.2016Renewal fee patent year 14
11.10.2017Renewal fee patent year 15
11.10.2018Renewal fee patent year 16
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.10.2003
AT26.12.2018
CY26.12.2018
CZ26.12.2018
DK26.12.2018
EE26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
MC26.12.2018
NL26.12.2018
RO26.12.2018
SE26.12.2018
SI26.12.2018
SK26.12.2018
TR26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
[2021/32]
Former [2021/26]AT26.12.2018
CY26.12.2018
CZ26.12.2018
DK26.12.2018
EE26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
MC26.12.2018
NL26.12.2018
RO26.12.2018
SE26.12.2018
SI26.12.2018
SK26.12.2018
TR26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2020/29]AT26.12.2018
CZ26.12.2018
DK26.12.2018
EE26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
MC26.12.2018
NL26.12.2018
RO26.12.2018
SE26.12.2018
SI26.12.2018
SK26.12.2018
TR26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2020/17]AT26.12.2018
CZ26.12.2018
DK26.12.2018
EE26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
NL26.12.2018
RO26.12.2018
SE26.12.2018
SI26.12.2018
SK26.12.2018
TR26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2020/13]AT26.12.2018
CZ26.12.2018
DK26.12.2018
EE26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
NL26.12.2018
RO26.12.2018
SE26.12.2018
SI26.12.2018
SK26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2019/48]AT26.12.2018
CZ26.12.2018
DK26.12.2018
EE26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
NL26.12.2018
RO26.12.2018
SE26.12.2018
SK26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2019/46]AT26.12.2018
CZ26.12.2018
EE26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
NL26.12.2018
RO26.12.2018
SE26.12.2018
SK26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2019/40]CZ26.12.2018
EE26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
NL26.12.2018
RO26.12.2018
SE26.12.2018
SK26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2019/37]CZ26.12.2018
EE26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
NL26.12.2018
RO26.12.2018
SE26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2019/35]CZ26.12.2018
ES26.12.2018
FI26.12.2018
IT26.12.2018
NL26.12.2018
SE26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2019/34]FI26.12.2018
IT26.12.2018
NL26.12.2018
SE26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2019/33]FI26.12.2018
NL26.12.2018
SE26.12.2018
BG26.03.2019
GR27.03.2019
PT26.04.2019
Former [2019/30]FI26.12.2018
NL26.12.2018
SE26.12.2018
BG26.03.2019
GR27.03.2019
Former [2019/25]FI26.12.2018
SE26.12.2018
BG26.03.2019
GR27.03.2019
Former [2019/22]FI26.12.2018
BG26.03.2019
Former [2019/21]FI26.12.2018
Documents cited:Search[X] US6391342  (HENRIKSEN KRISTIAN LUND et al.)
 [X] EP0247983  (HAESSLE AB et al.)
 [XP] WO03061584  (UNIV MISSOURI et al.)
 [X] US2002076435  (HAO WEI-HUA et al.)
 [X] US5814338  (VERONESI PAOLO ALBERTO et al.)
 [X] US6159499  (SETH PAWAN et al.)
 [X] WO9850019  (SAGE PHARMACEUTICALS INC et al.)
 [X] EP0960620  (RANBAXY LAB LTD et al.)
 [X] DE19801811  (STADA ARZNEIMITTEL AG et al.)
 [X] US6306435  (CHEN GAN-LIN et al.)
 [X] WO0226210  (GENEVA PHARMACEUTICALS INC et al.)
 [X] US5817338  (BERGSTRAND PONTUS JOHN ARVID et al.)
 [X] US5840737  (PHILLIPS JEFFREY OWEN et al.)
 [X] US6077541  (CHEN CHIH-MING et al.)
by applicantJPS62277322
 WO0189483
 JP2001526213
 US6274173
 US6093734
 US4045563
 US4686230
 US4873337
 US4965269
 US5021433
 JPS63301816
 JPS6150978
 US4628098
 JPH10195068
 WO9821201
 JPS5262275
 JPS54141783
 WO0078745
 WO0183473
 JPS6122079
 JPS646270
 JPS63146882
 WO9602535
 JP2002187890
 WO0230920
 WO03027098
 JPS63301826
 WO0132652
 JPH10504290
   SYNTHETIC COMMUNICATIONS, vol. 17, 1987, pages 1887
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.